ATOUT CAPITAL assisted IMPLANET in structuring and executing a new €4.5 million capital increase, carried out with preferential subscription rights maintained on the Growth segment of Euronext Paris. The transaction benefited from a 100% guarantee.
Thanks to this fundraising, IMPLANET now has the resources needed to accelerate the rollout of its strategy: (i) strengthen its commercial presence in the United States, (ii) launch products co-developed with SANYOU MEDICAL, and (iii) position itself as the exclusive distributor in Europe and the United States of surgical assistance devices developed by its partners.
This transaction marks the fifth deal completed by ATOUT CAPITAL’s team on behalf of IMPLANET and once again confirms its recognized expertise in the healthcare sector.
